top of page

 

OTC PHARMACEUTICALS / FDA

 

Drug product
compliance.

 

A clear path.
For complex products.

 

FDA regulatory support for pharmaceutical and over-the-counter drug products.

 

DISCUSS YOUR PRODUCT ↗

 

 

Pathway                                                       Register                                                       Represent                                                    Import

 

01 / PHARMACEUTICALS

 

Choose
your pathway.

 

Product characteristics inform the regulatory route.

 

01 / FDA

 

IND & NDA Support

 

We assist clients with pharmaceutical regulatory requirements, including Investigational New Drug (IND) and
New Drug Application (NDA) pathways.

 

02 / FDA

 

OTC & Innovative Products

 

OTC products must comply with applicable current monographs. Innovative products may fall outside established
categories or into more than one category. We outline the factors involved so you can make informed pathway
decisions.

 

 

02 / PHARMACEUTICALS

 

Register
your establishment.

 

Support for domestic and foreign drug establishments.

 

01 / FDA

 

Drug Establishment Registration

 

Domestic and foreign establishments that manufacture, prepare, propagate, compound, or process drugs must
register with FDA. We help clients understand the registration requirements relevant to their operations.

 

 

03 / PHARMACEUTICALS

 

Your U.S.
point of contact.

 

A U.S. representative for foreign establishments.

 

01 / FDA

 

U.S. Agent

 

Foreign establishments that manufacture, repack, or relabel drug products for import to the United States must
register with FDA and identify a U.S. Agent. The agent maintains a U.S. address and serves as the facility’s
representative before FDA.

 

 

04 / PHARMACEUTICALS

 

Prepare
for import.

 

Registration information matters at the border.

 

01 / FDA

 

Import Readiness

 

Every importer of drug products into the United States must provide FDA with the registration number of the
foreign manufacturer, repacker and/or relabeler. Failure to provide this information can result in detention or
refusal of the products.

 

 

CONTACT US

 

Plan your
next step.

 

Discuss your product, regulatory pathway, and U.S. market needs with Provision Consulting Group.

 

CONTACT OUR TEAM ↗

 

bottom of page